Impact investment: Gray areas
The notion of delivering measurable positive social and environmental impact while simultaneously generating risk-adjusted financial returns has struck a chord with many LPs. But impact strategies can still be a tough sell
Oliver Niedermaier doesn’t like to use the term “impact investment” even though it’s an accurate description of what he does. Tau Investment, the firm he leads, focuses solely on environmental...
More on Investments
Latest News
Corporate VCs & climate change: Good citizens
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Panacea leads $40m Series C for China's XWPharma
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Tencent backs Chinese healthcare cloud services platform
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Chinese mouse-based drug testing specialist raises $143m
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.